Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They would need to convert them into common, but currently it would not be possible. Personally I do not believe the short selling scenario will apply right now.
In my opinion it will be held in between the 27th and the 30th of December (personal feeling).
I agree. If it closes above 0.35 I believe next run is to 0.5 almost straight.
Main difference, as previously stated, is that preferred usually receive a dividend and have no voting power. Sometimes preferred shares have a liquid market themselves and they openly trade. However I do not think this will be the case, mainly because of the exchange common is currently trading and the fact that they will be initially concentrated in 2 hands (Cogn. and the upcoming unrelated investor).
It depends on the fact that the stake would grant control or not. But if the amount is in the range you speculate (I would speculate no more than 15), then long term investors are IMO basically whiped out.
Usually a preferred stock holds a value of 1K, this is common usage in finance deals.
Actually a September 8K reported that the co. anticipated the release of interim blinded data. Plus at Asco we have been told that some investigators were working on a paper. So I believe investors are only awaiting what they have been told would happen.
Al4oor, relax, it isn't NW. An unrelated investor was mentioned. Besides it, at this point, even any other investor that steps in for a long ride is better, IMO, than previous recent financings.
Today it would be perfect for news...
Obviously not. It's imo just for dilutive purposes.
As I have already said, imo the 10Q had lots of negatives that ppl in here prefer not to see, but the market understood them very well.
Let me remind you that for an investor the only thing that matters is, like it or not, the stock price.
IMO 10Q was really bad, but IMO it might hold the price. This kind of movement in early hours trading are typical and might come back in green in the afternoon. Let's see.
It seems like the book will hold 0.29 at the opening.
Changed nick? LOL!
Too bad that the 8K esplicitly talked about "interim blinded data", and didn't mention at all PFS.
interim blinded data...what ya talking about?
IMO very telling point of view. Thanks.
If you observation is correct IMO we will have a nasty R/S soon and IMO we could say bye bye to our investment.
I haven't seen any such mention for the US. Maybe they are willing to partner in the US and go it alone in UK and EU.
If news around, better release them tomorrow as I didn't read this 10Q to be any positive at all for current common shareholders.
Read the 10Q again: an officer and a third party got paid a hefty part of that loan back in 2017.
IMO it simply means that a R/S is shortly in the cards and/or a big increase in authorized shares. Take into account those that need to be issued with the preferred, related warrants, and the 15% for incentive plan...and I believe shortly the authorized shares will reach a very very huge number...
Two info in a row in the recent 10Q:
----------------------
During October and November, the Company has been in discussions with unrelated investors for a Series A Preferred Stock financing, which the Company expects to close shortly.
Following the discussions with investors, on November 19, 2017 the Company’s Board approved a new plan for equity awards of fifteen percent of the authorized shares at present, to take account of employee and director performance over the last approximately 6 years and anticipated performance over the next approximately 2 years. The awards are subject to various vesting provisions, forfeiture and acceleration provisions tied to milestones over the next 2 years. The Company is now undertaking the steps for implementation.
----------------------
15% of authorized shares at present...
IMO you are very right on this.
You are missing that 1 preferred share could be convertible (once shares are available) in "n" common shares (plus warrants).
IMO to me it looks more favorable to Cog. than the MFN clause.
Looks correct to me either.
That doesn't look good to me at all.
The fact that the yellow curve (UCLA) seems superior to Optune only after about 4 years and that for a small % of patients, is not what I would have expected, moreover, given possible wrong estimates, it might even look worse.
I do not believe price movement was due to financing.
Plus, trading volume compared to issuable shares is not in favor of that possibility.
Moreover, if it was due to that, you would have seen a price increase toward the end of the trading session.
Yes, this is by far the most probable scenario, LOL! Please! LOL!
I would hint 200! LOL.
Dunno what ya talking about.
Obviously they don't. However, it is increasingly risky to have a short position opened right now, because news could come any day. Besides all, the amount of time passed IMO makes next week the perfect timing for SEC investigation news and/or interim blinded data.
That was short covering and I believe all shares short have been covered.
That said, I believe they decided to cover their (small)short because news is imminent, I suspect at the very early of next week.
Cheers.